BASF, one of the world's largest chemical companies, is trying a new approach in its bid to acquire smaller rival Evonik. After Evonik rejected an offer worth more than €11 billion, BASF has shifted tactics, sending letters to key stakeholders that include commitments to protect jobs and plants. The move signals a more conciliatory strategy as the German chemical giant seeks to revive its takeover push.
The background of the bid
BASF has been circling Evonik since September, when reports first emerged of its interest in the specialty chemicals maker. Evonik, which produces ingredients for pharmaceuticals, coatings, and animal feed, is a major player in the sector and would significantly expand BASF's portfolio. However, Evonik's management has so far resisted BASF's advances, turning down the latest offer of over €11 billion.
The rejection prompted BASF to rethink its approach. Instead of simply raising the price, the company is now appealing directly to those with influence over Evonik's future: the RAG Foundation, which holds a majority stake in Evonik, and officials in North Rhine-Westphalia, the German state where Evonik is headquartered. By floating commitments on jobs and plant operations, BASF is attempting to address concerns that a takeover could lead to layoffs or facility closures—a sensitive issue in a region with a strong industrial heritage.
Why the softer touch matters
In Germany, large corporate takeovers often face political and social scrutiny, especially when they involve significant job losses or regional impacts. The RAG Foundation, which manages the legacy of Germany's coal mining industry, has a mandate to preserve jobs and support the region's transition. By offering assurances, BASF hopes to ease these concerns and build goodwill among stakeholders who could influence Evonik's decision.
This tactic is not uncommon in M&A. Companies often use public commitments to win over employees, unions, and local politicians, creating pressure on the target's board to reconsider. For BASF, a softer approach may be more effective than simply increasing the financial offer, especially if the main obstacle is not price but the perceived social and operational risks of a merger.
What it means for investors
For investors, the outcome of this bid could have significant implications. If BASF succeeds, it would create a chemical giant with a broader product range and potentially greater pricing power. That could be positive for BASF shareholders, but it also carries integration risks. Mergers of this size often face challenges in combining corporate cultures and operations, and the promised job and plant commitments could limit cost-cutting opportunities.
For Evonik shareholders, the offer represents a potential premium, but the company's management has argued that its standalone strategy offers better long-term value. Investors will be watching closely to see whether BASF's new approach leads to a revised offer or a breakdown in talks.
The broader M&A environment in Europe has been active, with deals like J&J and Blackstone leading a busy Monday in the US. However, cross-border and domestic deals in Germany often face additional hurdles, as seen in this case.
What to watch next
The key question is whether the RAG Foundation and local officials will respond positively to BASF's overtures. If they signal support, it could put pressure on Evonik's board to engage in more constructive talks. Conversely, if they side with Evonik's management, BASF may have to decide whether to walk away or launch a hostile bid—a rare and risky move in Germany.
Investors should also monitor any regulatory signals. A deal of this size would likely face antitrust review, both in Germany and at the EU level. While the two companies operate in different segments of the chemical industry, there could be overlaps that regulators scrutinize.
For now, BASF's softer touch is a calculated gamble. By appealing to stakeholders' concerns, it hopes to break the deadlock without escalating the fight. Whether it works remains to be seen, but the outcome will be closely watched by investors in both companies and by the broader chemical sector.
As the situation develops, keep an eye on BASF's renewed push to acquire Evonik and any updates from the RAG Foundation. The chemical industry is a bellwether for the broader economy, and this deal could signal how confident companies are in the global growth outlook.


